PIK3CA and neoplasm: As a member of the epidermal growth factor family of receptor tyrosine kinases, HER2 heterodimerisation leads to signalling via the RAS/MAPK and PI3K/Akt pathways to induce tumour cell proliferation, invasion and metastasis [42].